Investor Alert: Kaplan Fox Announces Investigation Of MiMedx

February 20, 2018

Responsive image

NEW YORK, Feb. 20, 2018 /PRNewswire/ — Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating MiMedx Group, Inc. (“MiMedx” or the “Company”) (NASDAQ: MDXG), a developer and marketer of regenerative and therapeutic biologics, concerning potential securities law violations….

Category: Precious Metals